News

MAIA Biotechnology to Present at Two Investor Conferences in April 2024

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology to Present at Two Investor Conferences in April 2024.

04/05/2024

MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024.

01/05/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is MAIA Biotechnology, Inc. (MAIA) a buy, sell, or hold?

MAIA Biotechnology, Inc. (MAIA) can sell. Click on Rating Page for detail.

What is MAIA Biotechnology, Inc.'s stock price?

The price of MAIA Biotechnology, Inc. (MAIA) is 3.135 and it was updated on 2024-05-02 13:00:41.

Is MAIA Biotechnology, Inc. (MAIA) overvalued or undervalued?

Currently MAIA Biotechnology, Inc. (MAIA) is in undervalued.

News

From:

To:

News
MAIA Biotechnology: Significantly Undervalued With Novel Mechanism And Impressive Early Data Lead asset THIO has a unique telomere-targeting mechanism and has reported impressive preliminary results in NSCLC. THIO's 90%+ disease control rate in second- and third-line NSCLC is an improvement over current standard of care. Plans to pursue accelerated approval in NSCLC in 2025 and has the potential to become a new standard of care. Thu, Jan. 04, 2024
Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now MAIA Biotechnology, Inc. (MAIA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. Fri, Dec. 01, 2023
MAIA Biotechnology to Present Preliminary Safety and Efficacy Data from THIO-101 Phase 2 Clinical Trial at European Society for Medical Oncology Congress 2023 CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology to Present Preliminary Safety and Efficacy Data from THIO-101 Phase 2 Clinical Trial at ESMO Congress 2023. Thu, Oct. 19, 2023
MAIA Biotechnology: Progress In The THIO-101 Trial Sets Up A 2023 Catalyst MAIA's THIO-101 trial of 6-thio-2-deoxyguanosine in non-small cell lung cancer had enrolled 29 patients as of a June 20 update from the company. The first two patients in the trial have achieved continued survival at 10 and 11 months following the start of treatment. MAIA has enough cash to make it to an update from the trial, but another cash raise could be ahead. Sat, Jul. 01, 2023
7 Up-and-Coming Stocks to Buy for the Next Decade In arguably most cases involving expert financial advice, you will encounter guidance toward established enterprises, not up-and-coming stocks to buy. While the latter category certainly dials up the heat in terms of overall sexiness, some folks just can't handle adventurous portfolios. Thu, Jun. 29, 2023

SEC Filings

SEC Filings
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/30/2024
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/26/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 04/23/2024
MAIA Biotechnology, Inc. (MAIA) - S-8 SEC Filings 04/19/2024
MAIA Biotechnology, Inc. (MAIA) - DEF 14A SEC Filings 04/16/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 04/02/2024
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/02/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 03/26/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 03/25/2024
MAIA Biotechnology, Inc. (MAIA) - 424B5 SEC Filings 03/25/2024
MAIA Biotechnology, Inc. (MAIA) - D SEC Filings 03/21/2024
MAIA Biotechnology, Inc. (MAIA) - 10-K - Current report SEC Filings 03/21/2024
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/18/2024
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/15/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 03/13/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 03/08/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 03/06/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 02/27/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 02/23/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 02/14/2024
MAIA Biotechnology, Inc. (MAIA) - 424B5 SEC Filings 02/14/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 01/30/2024
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 01/26/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 01/18/2024
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 01/03/2024
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 12/21/2023
MAIA Biotechnology, Inc. (MAIA) - D SEC Filings 11/29/2023
MAIA Biotechnology, Inc. (MAIA) - 3 SEC Filings 11/20/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 11/17/2023
MAIA Biotechnology, Inc. (MAIA) - 424B5 SEC Filings 11/17/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 11/16/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 11/15/2023
MAIA Biotechnology, Inc. (MAIA) - 424B5 SEC Filings 11/15/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 11/13/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 11/07/2023
MAIA Biotechnology, Inc. (MAIA) - 10-Q - Quarterly Report SEC Filings 11/07/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 10/30/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 10/03/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 09/28/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 09/01/2023
MAIA Biotechnology, Inc. (MAIA) - 424B5 SEC Filings 09/01/2023
MAIA Biotechnology, Inc. (MAIA) - EFFECT SEC Filings 08/24/2023
MAIA Biotechnology, Inc. (MAIA) - S-3 SEC Filings 08/15/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 08/08/2023
MAIA Biotechnology, Inc. (MAIA) - 10-Q - Quarterly Report SEC Filings 08/08/2023
MAIA Biotechnology, Inc. (MAIA) - RW SEC Filings 07/18/2023
MAIA Biotechnology, Inc. (MAIA) - FWP SEC Filings 07/11/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 07/11/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 07/10/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 07/05/2023
MAIA Biotechnology, Inc. (MAIA) - S-8 SEC Filings 06/30/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 06/20/2023
MAIA Biotechnology, Inc. (MAIA) - FWP SEC Filings 06/09/2023
MAIA Biotechnology, Inc. (MAIA) - S-1 SEC Filings 06/08/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 06/05/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 05/30/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 05/22/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 05/17/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 05/08/2023
MAIA Biotechnology, Inc. (MAIA) - 10-Q - Quarterly Report SEC Filings 05/08/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 05/01/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/28/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 04/27/2023
MAIA Biotechnology, Inc. (MAIA) - 424B3 SEC Filings 04/27/2023
MAIA Biotechnology, Inc. (MAIA) - 424B4 SEC Filings 04/26/2023
MAIA Biotechnology, Inc. (MAIA) - EFFECT SEC Filings 04/25/2023
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 04/21/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/21/2023
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 04/20/2023
MAIA Biotechnology, Inc. (MAIA) - FWP SEC Filings 04/20/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 04/20/2023
MAIA Biotechnology, Inc. (MAIA) - DEF 14A SEC Filings 04/19/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/19/2023
MAIA Biotechnology, Inc. (MAIA) - FWP SEC Filings 04/18/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 04/18/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/18/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/17/2023
MAIA Biotechnology, Inc. (MAIA) - FWP SEC Filings 04/11/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 04/11/2023
MAIA Biotechnology, Inc. (MAIA) - FWP SEC Filings 04/07/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/05/2023
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 04/04/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/04/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 04/03/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/28/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 03/24/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/24/2023
MAIA Biotechnology, Inc. (MAIA) - 10-K - Current report SEC Filings 03/24/2023
MAIA Biotechnology, Inc. (MAIA) - 3 SEC Filings 03/23/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/22/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/20/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 03/17/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/14/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/13/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/10/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/09/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/08/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/07/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/06/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/03/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/02/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 03/01/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 02/23/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 02/22/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 02/21/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 02/17/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 02/16/2023
MAIA Biotechnology, Inc. (MAIA) - SC 13G SEC Filings 02/14/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 02/14/2023
MAIA Biotechnology, Inc. (MAIA) - FWP SEC Filings 02/13/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K/A - Current report SEC Filings 02/13/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 02/13/2023
MAIA Biotechnology, Inc. (MAIA) - S-1 SEC Filings 02/06/2023
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 02/06/2023
MAIA Biotechnology, Inc. (MAIA) - 10-Q/A - Quarterly Report SEC Filings 02/06/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 01/27/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 01/18/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 01/06/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 01/04/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 01/03/2023
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 12/29/2022
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 12/27/2022
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 12/22/2022
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 12/08/2022
MAIA Biotechnology, Inc. (MAIA) - 4/A SEC Filings 11/23/2022
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 11/22/2022
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 11/09/2022
MAIA Biotechnology, Inc. (MAIA) - 10-Q - Quarterly Report SEC Filings 11/09/2022
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 09/21/2022
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 09/20/2022
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 09/13/2022
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 09/07/2022
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 09/01/2022
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 08/25/2022
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 08/22/2022
MAIA Biotechnology, Inc. (MAIA) - 10-Q - Quarterly Report SEC Filings 08/22/2022
MAIA Biotechnology, Inc. (MAIA) - SC 13D SEC Filings 08/10/2022
MAIA Biotechnology, Inc. (MAIA) - 4 SEC Filings 08/02/2022
MAIA Biotechnology, Inc. (MAIA) - S-8 SEC Filings 08/01/2022
MAIA Biotechnology, Inc. (MAIA) - 8-K - Current report SEC Filings 08/01/2022
MAIA Biotechnology, Inc. (MAIA) - 424B4 SEC Filings 07/29/2022
MAIA Biotechnology, Inc. (MAIA) - EFFECT SEC Filings 07/28/2022
MAIA Biotechnology, Inc. (MAIA) - EFFECT SEC Filings 07/28/2022
MAIA Biotechnology, Inc. (MAIA) - SEC STAFF LETTER SEC Filings 07/27/2022
MAIA Biotechnology, Inc. (MAIA) - CERT SEC Filings 07/27/2022
MAIA Biotechnology, Inc. (MAIA) - 8-A12B SEC Filings 07/27/2022
MAIA Biotechnology, Inc. (MAIA) - 3 SEC Filings 07/27/2022
MAIA Biotechnology, Inc. (MAIA) - CORRESP SEC Filings 07/25/2022
MAIA Biotechnology, Inc. (MAIA) - UPLOAD SEC Filings 07/21/2022
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 07/21/2022
MAIA Biotechnology, Inc. (MAIA) - CORRESP SEC Filings 07/21/2022
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 07/20/2022
MAIA Biotechnology, Inc. (MAIA) - CORRESP SEC Filings 07/20/2022
MAIA Biotechnology, Inc. (MAIA) - UPLOAD SEC Filings 07/19/2022
MAIA Biotechnology, Inc. (MAIA) - FWP SEC Filings 07/14/2022
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 07/13/2022
MAIA Biotechnology, Inc. (MAIA) - FWP SEC Filings 07/13/2022
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 06/29/2022
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 06/28/2022
MAIA Biotechnology, Inc. (MAIA) - CORRESP SEC Filings 06/28/2022
MAIA Biotechnology, Inc. (MAIA) - UPLOAD SEC Filings 06/06/2022
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 05/31/2022
MAIA Biotechnology, Inc. (MAIA) - CORRESP SEC Filings 05/31/2022
MAIA Biotechnology, Inc. (MAIA) - UPLOAD SEC Filings 05/23/2022
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 05/16/2022
MAIA Biotechnology, Inc. (MAIA) - S-1/A SEC Filings 04/29/2022
MAIA Biotechnology, Inc. (MAIA) - CORRESP SEC Filings 04/29/2022
MAIA Biotechnology, Inc. (MAIA) - UPLOAD SEC Filings 04/25/2022
MAIA Biotechnology, Inc. (MAIA) - SEC STAFF LETTER SEC Filings 04/25/2022
MAIA Biotechnology, Inc. (MAIA) - S-1 SEC Filings 04/11/2022
MAIA Biotechnology, Inc. (MAIA) - CORRESP SEC Filings 04/11/2022
MAIA Biotechnology, Inc. (MAIA) - UPLOAD SEC Filings 03/01/2022
MAIA Biotechnology, Inc. (MAIA) - DRSLTR SEC Filings 02/14/2022
MAIA Biotechnology, Inc. (MAIA) - DRS/A SEC Filings 02/14/2022
MAIA Biotechnology, Inc. (MAIA) - UPLOAD SEC Filings 01/10/2022
MAIA Biotechnology, Inc. (MAIA) - DRSLTR SEC Filings 12/22/2021
MAIA Biotechnology, Inc. (MAIA) - DRS/A SEC Filings 12/22/2021
MAIA Biotechnology, Inc. (MAIA) - UPLOAD SEC Filings 11/16/2021
MAIA Biotechnology, Inc. (MAIA) - DRS SEC Filings 10/15/2021

Press Releases

StockPrice Release
Maia biotechnology announces share purchase by director adelina louie in private placement 04/30/2024
Maia biotechnology announces share purchase by director stan smith, ph.d. in private placement 04/29/2024
Maia biotechnology announces $1.00 million private placement 04/23/2024
Maia biotechnology to present at two investor conferences in april 2024 04/05/2024
Maia biotechnology announces share purchases by directors cristian luput and ramiro guerrero 03/28/2024
Maia biotechnology announces share purchase by director adelina louie in private placement 03/26/2024
Maia biotechnology announces $1.33 million private placement 03/26/2024
Maia biotechnology announces share purchase by director stan smith, phd in a $2.9 million private placement 03/22/2024
Maia biotechnology welcomes prominent medical oncology scientist dr. saadettin kilickap to its scientific advisory board 03/21/2024
Maia biotechnology to participate in the 36th annual roth conference 03/07/2024
Maia biotechnology and nationwide children's hospital announce presentation of thio's potency in pediatric brain tumors at american association of cancer research annual meeting 03/06/2024
Maia biotechnology announces strong efficacy of thio as third-line treatment for non-small cell lung cancer patients 03/06/2024
Maia biotechnology ceo details immuno-oncology cancer treatment candidates and development pipeline in letter to shareholders 03/05/2024
Maia biotechnology appoints leading immuno-oncology scientist dr. remus vezan as scientific advisor 02/27/2024
Maia biotechnology completes enrollment in thio-101 phase 2 clinical trial for non-small cell lung cancer 02/22/2024
Maia biotechnology announces publication in nature communications on positive effects of thio for potential treatment of small cell lung cancer 02/07/2024
Maia biotechnology announces publication of international pct patent application covering anticancer telomere-targeting compounds 01/24/2024
Maia biotechnology provides positive phase 2 clinical updates for lead anticancer agent and outlines targeted milestones for 2024 01/17/2024
Maia biotechnology to present at biotech showcase 2024 on january 9, 2024 01/05/2024
Maia biotechnology announces dose selection in thio-101 phase 2 clinical trial for non-small cell lung cancer 12/19/2023
Maia biotechnology announces closing of $4 million registered direct offering 11/17/2023
Maia biotechnology (nyse: maia) has received fda orphan drug designation for thio as a treatment for most aggressive brain cancer 11/17/2023
Maia biotechnology announces $4 million registered direct offering 11/15/2023
Fda grants orphan drug designation to maia biotechnology for thio as a treatment for glioblastoma 11/10/2023
Maia biotechnology reports positive phase 2 clinical trial data on its treatment for non-small cell lung cancer 10/31/2023
Maia biotechnology reveals higher anticancer potency of telomere-targeting compounds derived from thio 10/30/2023
Maia biotechnology announces 100% disease control in second-line non-small cell lung cancer demonstrating impressive positive preliminary efficacy data for ongoing thio-101 phase 2 trial 10/24/2023
Maia biotechnology to present preliminary safety and efficacy data from thio-101 phase 2 clinical trial at european society for medical oncology congress 2023 10/19/2023
Maia biotechnology's thio emerges as potential breakthrough in pediatric brain cancer therapy 10/17/2023
Maia biotechnology to present latest findings for second generation thio program at turkish biochemical society's international biochemistry congress 2023 10/17/2023
Maia biotechnology reveals new data showing thio's potent anticancer activity in aggressive pediatric brain cancer 10/12/2023
Maia biotechnology accelerates enrollment in thio-101 phase ii clinical trial as efficacy is observed in dosed patients 10/10/2023
Maia biotechnology announces potent anticancer activity of thio in gliomas 10/10/2023
Maia biotechnology announces fda clearance of ind application for thio, a first-in-class telomere targeting agent for the treatment of non-small cell lung cancer 10/03/2023
Maia biotechnology announces share repurchase program 09/28/2023
Maia biotechnology reports second quarter 2023 financial results and provides updates for thio-101 phase 2 trial for non-small cell lung cancer 08/08/2023
Maia biotechnology reports updates on disease control rates for thio-101 phase 2 trial for advanced non-small cell lung cancer 07/11/2023
Maia biotechnology reports updates on preliminary survival data for thio-101 phase 2 trial for advanced non-small cell lung cancer 07/10/2023
Maia biotechnology, inc. announces pricing of public offering 04/24/2023
Maia biotechnology reports full year 2022 financial results and provides corporate update 03/24/2023
Maia biotechnology announces no exposure to silicon valley bank 03/13/2023
Adding multimedia: maia biotechnology's telomere-targeting agent thio, in combination with checkpoint inhibitor immune therapies atezolizumab (anti-pd-l1) or pembrolizumab (anti-pd-1), demonstrated significantly greater tumor inhibition 02/13/2023
Maia biotechnology's telomere-targeting agent thio, in combination with checkpoint inhibitor immune therapies atezolizumab (anti-pd-l1) or pembrolizumab (anti-pd-1), demonstrated significantly greater tumor inhibition 02/13/2023
Maia biotechnology advances new telomere-targeting molecule program 01/17/2023
Maia biotechnology to participate in four upcoming investor conferences 01/05/2023
Maia biotechnology holds successful pre-ind meeting with fda for planned us expansion of thio-101 phase 2 trial for non-small cell lung cancer 12/20/2022
Maia biotechnology: invitation to the thinkequity conference 10/12/2022
Maia biotechnology to participate in thinkequity conference 10/06/2022
Maia biotechnology to present at eortc-nci-aacr symposium on molecular targets and cancer therapeutics 09/29/2022
Maia biotechnology to present design of thio-101 trial at european society for medical oncology (esmo) congress 2022 09/06/2022
Maia biotechnology reports second quarter 2022 financial results and provides corporate update 08/22/2022
Maia biotechnology announces closing of initial public offering 08/01/2022
Maia biotechnology announces pricing of initial public offering 07/27/2022

More Headlines

News
MAIA Biotechnology (MAIA) Up on Positive Data From NSCLC Study MAIA Biotechnology (MAIA) gains on encouraging data on lead candidate from Part A of its mid-stage study in advanced non-small cell lung cancer. 04/12/2023
MAIA Biotechnology to Participate in Four Upcoming Investor Conferences CHICAGO--( BUSINESS WIRE )--MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA,” “the Company”) announced today that the management team will participate in the four upcoming investor conferences as follows: 01/05/2023
MAIA Biotechnology to Present at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs, announced today that it will present the results of a study of the anticancer agent 6-thio-dG (THIO) in hepatocellular carcinoma (HCC) in vitro and in vivo models at the EORTC-NCI-AACR (ENA) Symposium on Molecular Targets and Cancer Therapeutics. The symposium is taking place Oct. 26-28, 2022 09/29/2022
MAIA Biotechnology to Present Design of THIO-101 Trial at European Society for Medical Oncology (ESMO) Congress 2022 CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA,” “the Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it will present the design of its ongoing THIO-101 trial at the European Society for Medical Oncology (ESMO) Congress 2022, being held from September 9th to 13th in Paris, France. THIO is a telomere-targeting agent currently in clinical development to evaluate its activity in non-small ce 09/06/2022

Unlock

MAIA Ratings Summary

MAIA Quant Ranking